June 9, 2020 / 12:49 PM / a month ago

BRIEF-Beyondspring's Neutropenia Trial Shows Positive Results

June 9 (Reuters) - Beyondspring Inc:

* BEYONDSPRING’S PROTECTIVE-2 (STUDY 106) PHASE 2 TRIAL FOR CHEMOTHERAPY-INDUCED NEUTROPENIA SHOWS POSITIVE RESULTS IN CHEMOTHERAPY OPTIMIZATION WITH POTENTIALLY BETTER CLINICAL OUTCOMES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below